Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma
Year: 2024
Type: article
Abstract: This study explores the potential of DNA hydrogels as a novel approach for diagnosing and treating Oral Squamous Cell Carcinoma (OSCC). In the experiment, DNA hydrogels are synthesized and loaded with Zinc Oxide Nanoparticles (ZnO NPs) and Cisplatin. In vitro experiments evaluated drug delivery efficacy and the effect on cancer cell viability. In vivo, studies used mice models to assess the therapeutic potential and antimicrobial activity of the DNA hydrogels. Results demonstrate that DNA hydrogels significantly improve the delivery of Cisplatin to cancer cells, potentially allowing for lower drug doses and reduced side effects. The combination of Cisplatin and ZnO NPs show the most potent antibacterial effect against bacterial strains associated with OSCC. Analysis indicates that ZnO NPs within the hydrogels improve the efficacy of contrast agents, facilitating earlier and more accurate tumor diagnosis. The findings highlight that DNA hydrogels loaded with therapeutic agents can enhance drug delivery and reduce side effects, while ZnO NPs improve tumor diagnosis. DNA hydrogels may represent a promising patient-centric approach for more effective OSCC treatment.
Source: Advanced Healthcare Materials
Authors: Dan Zhao, Lin Liu, Gang Ping Wang, Xi Cheng
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: bronze
Funder: Southwest Medical University
OpenAlex ID: W4405814516
